Clinical, functional, radiologic and quality of life characteristics in PI*SZ Alpha 1-Antitrypsin Deficiency (AATD) compared to PI*ZZ, PI*MZ and COPD without AATD: a retrospective cohort study.
C. Tirelli (Pavia, Italy), S. Ottaviani (Pavia, Italy), D. Piloni (Pavia, Italy), V. Barzon (Pavia, Italy), A. Balderacchi (Pavia, Italy), D. Ambruoso (Pavia, Italy), A. Corino (Pavia, Italy), F. Mariani (Pavia, Italy), I. Ferrarotti (Pavia, Italy), A. Corsico (Pavia, Italy)
Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Tirelli (Pavia, Italy), S. Ottaviani (Pavia, Italy), D. Piloni (Pavia, Italy), V. Barzon (Pavia, Italy), A. Balderacchi (Pavia, Italy), D. Ambruoso (Pavia, Italy), A. Corino (Pavia, Italy), F. Mariani (Pavia, Italy), I. Ferrarotti (Pavia, Italy), A. Corsico (Pavia, Italy). Clinical, functional, radiologic and quality of life characteristics in PI*SZ Alpha 1-Antitrypsin Deficiency (AATD) compared to PI*ZZ, PI*MZ and COPD without AATD: a retrospective cohort study.. 3427
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Differences of disease phenotypes in individuals with alpha-1-antitrypsin deficiency with genotypes PiZZ and PiSZ - Analysis from the German registry Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016
Prevalence of alpha-1 antitrypsin deficiency (AATD) and frequencies of alleles PI*S and PI*Z in patients with COPD in Brazil Source: Annual Congress 2013 –Assessing the prevalence of COPD in the general population Year: 2013
Prevalence of alpha-1-antitrypsin deficiency (A1AD) in patients with COPD. Source: Virtual Congress 2021 – COPD burden, epidemiology and management Year: 2021
Predicting clinical course of alpha 1 anti-trypsin deficiency (AATD) using GOLD 2011 classification Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013
Functional alterations of small airways in patients with alpha-1 antitrypsin deficiency (AATD) in a longitudinal study Source: Eur Respir J 2005; 26: Suppl. 49, 361s Year: 2005
Risk of cancer in individuals with severe alpha-1-antitrypsin deficiency (PiZZ) compared with the Swedish general population Source: Virtual Congress 2020 – Asthma and COPD: How genetic and environment influences its developement? Year: 2020
Differences in the disease phenotype and comorbidities between patients with COPD and alpha-1-antitrypsin deficiency - An analysis of the COSYCONET cohort Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD Year: 2016
Alpha 1-Antitrypsin deficiency (AATD) in patients with ARDS consequent to SARS-CoV-2 infection. Source: Virtual Congress 2021 – COVID – 19: treatments and predictive factors Year: 2021
Prevalence of a1 -antitrypsin PiZZ genotypes in patients with COPD in Europe: a systematic review Source: Eur Respir Rev, 29 (157) 200014; 10.1183/16000617.0014-2020 Year: 2020
Clinical consequences and longitudinal outcomes in PiMZ heterozygous a1-antitrypsin deficiency smokers from SPIROMICS Source: Virtual Congress 2021 – Pearls in immunology, outcome studies and clinical trials in asthma, alpha-1 antitrypsin deficiency and COPD Year: 2021
Survival in individuals with severe alpha 1-antitrypsin deficiency (PiZZ) in comparison to a general population with known smoking habits Source: Eur Respir J, 50 (3) 1700198; 10.1183/13993003.00198-2017 Year: 2017
Clinical considerations in individuals with a1 -antitrypsin PI*SZ genotype Source: Eur Respir J, 55 (6) 1902410; 10.1183/13993003.02410-2019 Year: 2020
Bronchiectasis but not emphysema is more prevalent in non-PiZ alpha-1 antitrypsin deficiency (AATD) COPD than in usual COPD Source: International Congress 2014 – Genetics and environmental factors underlying asthma and COPD Year: 2014
Pulmonary rehabilitation (PR) in patients with COPD due to alpha-1 antitrypsin deficiency (AATD): 15 years experience at the Maugeri Institute Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation Year: 2013
Alpha-1-antitrypsin deficiency in Kazakh subjects with COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016
The national alpha-1 antitrypsin deficiency registry in Poland Source: International Congress 2015 – Chronic airway disorders: miscellaneous aspects Year: 2015
Mortality in individuals with severe alpha-1-antitrypsin deficiency (PiZZ) Source: Eur Respir J 2006; 28: Suppl. 50, 144s Year: 2006
COPD in individuals with the PiMZ alpha-1 antitrypsin genotype Source: Eur Respir Rev, 26 (146) 170068; 10.1183/16000617.0068-2017 Year: 2017
Severity of lung disease in siblings with α-1-antitrypsin deficiency (AATD) Source: Annual Congress 2008 - COPD Year: 2008